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Sir,
We find the letter of Miki et al most interesting. As they state
postoperative infectious complications can be separated into
surgical site infections and remote infections. A surgical site
infection such as a wound infection, anastomotic leak or intra-
abdominal collection is an infection that occurs after surgery and
is associated specifically with the surgical procedure. Surgical site
infections can be further classified into incisional and organ/space
infections. A remote infection such as pneumonia is often
exogenous and occurs at sites not directly associated with the
surgical procedure. In our paper, we have shown that the modified
Glasgow Prognostic Score (mGPS) can predict postoperative
infectious complications. Miki et al pose the question can the
mGPS predict site-specific patterns in infectious complications? In
particular, is an elevated mGPS associated with a greater
proportion of patients with a remote infection?
In our cohort of 455 patients undergoing potentially curative
colorectal resections, 70 patients developed an infectious compli-
cation. There were 31 surgical site infections (14 anastomotic leak,
2 intra-abdominal collections and 15 wound infections) and 39
remote infections (6 septicaemia, 33 pneumonia). In those patients
with an infectious complication an elevated mGPS was not
associated with a greater proportion of patients with a remote
infection (P¼0.899). Clearly, the numbers of surgical site
infections and remote infections are relatively small and a larger
cohort would need to be studied to exclude the possibility of the
relationship posed by Miki et al.
Nevertheless, these results suggest that systemic inflammation
influences both surgical site infections and remote infections. A
plausible explanation for this, as outlined in our paper, is that the
systemic inflammatory response is associated with compromised
immune function.
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